https://biotechmorning.com/news/astrazeneca-cspc-extrahepatic-sirna-deal Biotech Morning en 2026-07-12T14:22:16.679Z AstraZeneca's $1.77 Billion Bet on the Organ Nobody Can Target https://biotechmorning.com/news/bundibugyo-ebola-american-infected-no-vaccine Biotech Morning en 2026-07-12T14:21:21.393Z The Ebola Strain Nobody Has a Vaccine For Just Infected an American https://biotechmorning.com/news/arpa-h-160-million-custom-gene-editing-thrive Biotech Morning en 2026-07-12T14:20:26.190Z Uncle Sam Just Bet $160 Million That Gene Editing Can Go Custom https://biotechmorning.com/news/vaccine-skeptic-nominee-emergency-health-role Biotech Morning en 2026-07-12T14:19:35.058Z The Man Who'd Rather Die Than Vaccinate His Kids Might Run U.S. Emergency Health https://biotechmorning.com/news/fda-slams-door-cheap-ozempic-knockoffs Biotech Morning en 2026-07-12T14:18:40.934Z The FDA Just Slammed the Door on Cheap Ozempic Knockoffs https://biotechmorning.com/news/lilly-zepbound-cheaper-single-dose-vials Biotech Morning en 2026-07-12T14:17:51.708Z Lilly Just Turned Zepbound Into a Costco-Style Bargain https://biotechmorning.com/news/novo-nordisk-wegovy-subscription-pricing Biotech Morning en 2026-07-12T14:16:55.615Z Novo Nordisk Wants You to Subscribe to Wegovy Like It's Netflix https://biotechmorning.com/news/ipsen-memo-therapeutics-bk-virus-deal Biotech Morning en 2026-07-12T14:15:56.170Z The Virus No One Has a Drug For (and the €700M Bet to Change That) https://biotechmorning.com/news/eplontersen-attr-cm-phase-3-failure Biotech Morning en 2026-07-12T14:14:55.389Z The Drug That Worked Perfectly and Still Failed https://biotechmorning.com/news/relacorilant-cortisol-ovarian-cancer-approval Biotech Morning en 2026-07-12T14:14:08.935Z The Drug That Turns Your Own Stress Hormones Against Cancer https://biotechmorning.com/news/moderna-flu-covid-combo-vaccine-eu-approval-2 Biotech Morning en 2026-07-11T14:21:05.752Z One Shot to Rule Them All: Moderna's Flu-COVID Combo Just Made History https://biotechmorning.com/news/arpa-h-160m-customizable-gene-therapy Biotech Morning en 2026-07-11T14:20:17.822Z The $160M Bet to Turn Gene Therapy Into a Copy Machine https://biotechmorning.com/news/gsk-hansoh-adc-sclc-phase-3-win Biotech Morning en 2026-07-11T14:19:26.794Z The Cancer That Kills Most Patients in a Year Just Met Its Match https://biotechmorning.com/news/pharma-tariff-shakedown-16-companies-blink Biotech Morning en 2026-07-11T14:18:36.223Z Pharma's Biggest Shakedown Just Got 16 Companies to Blink https://biotechmorning.com/news/ema-progestin-contraceptive-meningioma-risk Biotech Morning en 2026-07-11T14:17:43.987Z Millions of Women Use These Contraceptives. Europe Just Flagged a Brain Tumor Link. https://biotechmorning.com/news/liver-cancer-drug-manufacturing-rejection-fda Biotech Morning en 2026-07-11T14:16:54.936Z This Liver Cancer Drug Keeps Failing for a Reason Nobody Expected https://biotechmorning.com/news/germany-tougher-drug-pricing-reform-2026 Biotech Morning en 2026-07-11T14:16:04.595Z Germany Just Made It Harder to Sell Drugs in Europe's Biggest Market https://biotechmorning.com/news/bayer-apollo-contraceptives-equity-deal Biotech Morning en 2026-07-11T14:15:09.309Z Bayer Just Sold a Piece of Its Birth Control Empire (But Kept the Keys) https://biotechmorning.com/news/sanofi-subcutaneous-sarclisa-myeloma-convenience Biotech Morning en 2026-07-11T14:14:18.456Z Sanofi Just Gave Myeloma Patients Their Hours Back